Brown University

Neurotech S.a.

Elf Atochem S.a.

David H Rein

Edward J Doherty

Tyrone F Hazlett

Keith E Dionne

Nicholas F Warner

Brian M Cain

John F Mills

Bruno Vuillemin

Philippe Heim

Pascal Nicol

Paul Rempp

Pierre Lutz

Frank T Gentile

Weng Tao

Patrick A Tresco

Laura M Holland

Paul Francis Stabila

Brenda J Dean

Thomas Flanagan

Rebecca Li

Moses B I Goddard

Moses Bi Goddard

ARPE-19 cells were evaluated as a platform cell line for encapsulated and unencapsulated cell-based delivery technology. ARPE-19 cells were found to be hardy (the cell line is viable under stringent conditions, such as in central nervous system or intra-ocular environment); can be genetically modified to secrete the protein of choice; have a long life span; are of human origin; have good in vivo device viability; deliver efficacious quantity of growth factor; trigger no or low level host immune reaction, and are non-tumorigenic.

ARPE-19 as a platform cell line for encapsulated cell-based delivery

ARPE-19 cells were evaluated as a platform cell line for encapsulated and un-encapsulated cell-based delivery technology. ARPE-19 cells were found to be hardy (the cell line is viable under stringent conditions, such as in central nervous system or intra-ocular environment); can be genetically modified to secrete the protein of choice; has a long life span; is of human origin; has good in vivo device viability; delivers efficacious quantity of growth factor; triggers no or low level host immune reaction, and is non-tumorigenic.

A method for determining the viral retentivity of an external jacket of an implantable permselective macrocapsule. Viral retentivity describes the ability of an external jacket to retard the transport of virus particles across the jacket.

Microporous macrocapsules

A device is prepared having cells or tissue attached to a non-degradable filamentous matrix surrounded by a semi-permeable membrane. The matrix is preferably formed of a plurality of monofilaments twisted into a yarn or woven into a mesh, and can be in the form of a cylinder. When implanting the device, the semi-permeable membrane is preferably immunolsolatory, and the cells or tissue may produce a biologically active molecule to provide therapy. To enhance cell or tissue adhesion, the matrix is coated with extracellular matrix molecules or treated to provide a surface charge. The device can be made by inserting the matrix into a capsule formed of the semi-permeable membrane, distributing the cells or tissue on the matrix through an opening of the capsule, and sealing the opening of the capsule.

Cells or tissue attached to a non-degradable filamentous matrix encapsulated by a semi-permeable membrane

A sealed, implantable, encapsulation device (20) for diffusing a biologically active product or function to an individual which includes a substantially non-porous fitting (32) including an inner surface (33) defining an access port (34). A permselective, porous, membrane (21), having an interior surface (22), cooperates with the fitting inner surface (33) to form a storage cavity (23) therebetween. The membrane interior surface (22) is in substantially cell-tight dry sealing engagement with fitting (32) to seal cavity (23). Living cells (24) are disposed in the cavity (23) which are capable of secreting the biologically active product to an individual. The membrane (21) is of a material capable of permitting the passage of substances between the individual and cells required to provide the biological product or function. A plug member (35) is positioned in the access port (34) and seated in cell-tight sealing engagement with the fitting inner surface (33). A method for sealing the implantable encapsulation device (20) is also provided.

Method and apparatus for sealing implantable membrane encapsulation

Method and apparatus for sealing implantable, membrane encapsulation

A multifunctional anionic polymerization initiator which is in the form of a star-shaped polymer, and which is soluble in a nonpolar medium and is substantially free of residual double bonds. The initiator is denoted by the general formula (PA).sub.a N.sup.n- nLi.sup.+. PA is a polymer block of a vinylaromatic or diene monomer A. The variable 'a' is the number of branches in the block PA. N is a crosslinked core comprising no or practically no residual double bonds and has the formula (PMc)(RLi).sub.p. Mc is a monomer containing at least two polymerizable double bonds per molecule. PMc is a crosslinked core of at least one polymerized monomer Mc, containing 3 to 30% of residual double bonds in relation to the initial double bonds originating from the monomer Mc. R is an alkyl, aryl, arylalkyl, alkylaryl, cycloalkyl, or alkenyl. The variable 'p' is the number of residual double bonds in PMc which are neutralized by RLi. The variable 'n' is the number of anionic sites present in the crosslinked core N. A process of making and using the initiator to prepare star-shaped polymers.

Multifunctional initiator for obtaining star-shaped polymers by an

A multifunctional anionic polymerization initiator which is in the form of a star-shaped polymer soluble in an apolar medium and substantially free of residual double bonds. The initiator is denoted by the general formula (PA).sub.a N.sup.n- nLi.sup.+. PA is a polymer block of a vinylaromatic or diene monomer A. The variable 'a' is the number of branches in the block PA. N is a crosslinked core comprising no or practically no residual double bonds and has the formula (PMc)(RLi).sub.p. Mc is a monomer containing at least two polymerizable double bonds per molecule. PMc is a crosslinked core of at least one polymerized monomer Mc, containing 3 to 30% of residual double bonds in relation to the initial double bonds originating from the monomer Mc. R is an alkyl, aryl, arylalkyl, alkylaryl, cycloalkyl, or alkenyl. The variable 'p' is the number of residual double bonds in PMc which are neutralized by RLi. The variable 'n' is the number of anionic sites present in the crosslinked core N. A process of making and using the initiator to prepare star-shaped polymers.

Growing community of inventors

Providence, RI, United States of America

David H Rein